Market Tracker

04/25 5:16pm ET

Regulus Therapeutics Inc (NASDAQ:RGLS)

1.45
Delayed Data
As of Apr 25
 +0.05 / +3.57%
Today’s Change
0.94
Today|||52-Week Range
6.66
-35.56%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close1.40
Today’s open1.40
Day’s range1.40 - 1.45
Volume351,101
Average volume (3 months)1,007,142
Market cap$74.1M
Dividend yield--
Data as of 3:59pm ET, 04/25/2017

Growth & Valuation

Earnings growth (last year)-43.52%
Earnings growth (this year)+9.03%
Earnings growth (next 5 years)--
Revenue growth (last year)-94.25%
P/E ratioNM
Price/Sales99.52
Price/Book1.32

Competitors

 Today’s
change
Today’s
% change
CEMIChembio Diagnostics ...+0.10+1.65%
NAVBNavidea Biopharmaceu...+0.05+11.26%
LIFEaTyr Pharma Inc+0.10+3.17%
CTRVContraVir Pharmaceut...-0.32-27.12%
Data as of 4:01pm ET, 04/25/2017

Financials

Next reporting dateMay 11, 2017
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$1.2M
Annual profit (last year)-$81.8M
Net profit margin-6,853.94%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Paul C. Grint
COO, Chief Financial &
Accounting Officer
Joseph P. Hagan
Corporate headquarters
San Diego, California

Forecasts